ZTS

#394
Zoetis Inc. Class A Common Stock
77.6 6 USD
-0.78%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
77.56
77.96
Jahresspanne
0.78
147.90
Tagesänderung
-0.78%
Monatliche Änderung
-32.03%
6 month change
-39.47%
Jahresänderung
-46.92%
Vorheriger Schlusskurs
78.2 7
Open
77.8 2
Tief
77.5 6
High
77.9 6
Volumen
2 629
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 32.56 B
  • Employee 15 K
  • Founded N/A
  • CEO Kristin C. Peck
  • Website www.zoetis.com
  • Headquarter New Jersey, United States
  • FIGI BBG0039320N9
  • Industry Arzneimittelhersteller – spezialisierte und Generika
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
19.38
Preis-Umsatz-Verhältnis
5.44
Dividende je Aktie
0.53
Dividendenrendite in %
2.59

Zoetis Inc. Class A Common Stock

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

Nachrichten